ライフサイエンスコーパス: meningococcal meningitis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 nd a substantial effect on confirmed group A meningococcal meningitis.

2 cohort studies comprising 373 patients with meningococcal meningitis.

3 tions, such as outbreaks of yellow fever and meningococcal meningitis.

4 ally significant decline in risk of probable meningococcal meningitis across the age group targeted f

5 We studied the effect of PsA-TT on meningococcal meningitis and carriage in Chad during a s

6 We identified all reported cases of meningococcal meningitis and estimated the number of cas

7 o- or nasopharynx and the causative agent of meningococcal meningitis and meningococcemia, is capable

8 isseria meningitidis, the causative agent of meningococcal meningitis and septicemia, is an integral

9 Subsequently the patient developed meningococcal meningitis and was admitted to the neuroin

10 Epidemics of meningococcal meningitis are concentrated in sub-Saharan

11 incidence of suspected meningitis, probable meningococcal meningitis by age, and serogroup-specific

12 a pneumococcal seroprevalence study during a meningococcal meningitis epidemic in Western Burkina Fas

13 is and carriage in Chad during a serogroup A meningococcal meningitis epidemic.

14 After the major group A meningococcal meningitis epidemics in 1996-1997 (250,000

15 nsible for epidemics and almost all cases of meningococcal meningitis in the meningitis belt over the

16 No cases of serogroup A meningococcal meningitis occurred among vaccinated indiv

17 eningitis at a time when the epidemiology of meningococcal meningitis on the continent is changing ra

18 her children identified with pneumococcal or meningococcal meningitis or children with a cerebrospina

19 These associations did not seem to apply to meningococcal meningitis or viral meningitis.

20 Siblings of meningococcal meningitis patients also had lower educati

21 By contrast, meningococcal meningitis rates declined steadily, but re

22 s from 12 of 79 patients suspected of having meningococcal meningitis tested positive by both methods

23 a vaccine against the one cause of epidemic meningococcal meningitis that currently cannot be preven

24 al and H. influenzae meningitis, whereas for meningococcal meningitis the lower educational achieveme

25 nhanced surveillance, no case of serogroup A meningococcal meningitis was reported in the three vacci

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。